When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Looks Like A High-Quality Platform Play As Gvoke Sales Increase
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals (XERS) is a company that got on my radar about two weeks ago. Xeris is already a commercial stage biotech, and this past week saw a big rally in the stock as sales of its lead product, Gvoke, have started picking up.
Figure 1: Xeris Stock Chart (source: finviz)
Although I wish I had discovered this stock a little sooner, I discuss in this article why I believe Xeris is still a good value-pick for long term investors in the sector.
Xeris’ Non-Aqueous Formulation Technology Has Already Produced One